Impact of primary biliary cirrhosis on perceived quality of life: The UK-PBC national study

Mells, George F., Pells, Greta, Newton, Julia L., Bathgate, Andrew J., Burroughs, Andrew K., Heneghan, Michael A., Neuberger, James M., Day, Darren B. +4 more·2013·Hepatology
DOI 10.1002/hep.26365

Cited by (226)

Items 101–200 of 226

  1. Toward precision medicine in primary biliary cholangitis
    Marco Carbone, Vincenzo Ronca, Savino Bruno, Pietro Invernizzi, George F. Mells · 2016 · Digestive and Liver Disease
  2. Seladelpar: an investigational drug for the treatment of early-stage primary biliary cholangitis (PBC)
    Aaron Wetten, David E.J. Jones, Jessica Katharine Dyson · 2022 · Expert Opinion on Investigational Drugs
  3. Understanding fatigue and pruritus in primary biliary cholangitis
    Asma Faisal · 2024 · Clinical Liver Disease
  4. Home-based exercise in patients with refractory fatigue associated with primary biliary cholangitis: a protocol for the EXerCise Intervention in cholesTatic LivEr Disease (EXCITED) feasibility trial
    Alice Freer, Felicity Rhian Williams, Simon Durman, Jennifer Hayden, Palak Jitendrakumar Trivedi, Matthew James Armstrong · 2021 · BMJ Open Gastroenterology
  5. Clinical management of autoimmune liver diseases: juncture, opportunities, and challenges ahead
    Yangfan Chen, Ruofei Chen, Haiyan Li, Zongwen Shuai · 2025 · Immunologic Research
  6. Barriers to implementation of stratified care in primary biliary cholangitis: a scoping exercise
    Margaret Corrigan, Gideon Morris Hirschfield, Sheila Greenfield, Jayne M. Parry · 2019 · BMJ Open Gastroenterology
  7. Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis?
    Aaron Wetten, Laura Frances Ogle, George F. Mells, Vinod S. Hegade, Laura Jopson, Margaret Corrigan, Jeremy M. Palmer, Maja Johansson, Torbjörn Carl Bäckström, Magnus Doverskog et al. · 2022 · Canadian Journal of Gastroenterology and Hepatology
  8. Fatigue in people with primary biliary cholangitis: a position paper from the European Reference Network for Rare Liver Diseases
    Ozgur M Koc, Anne Christin Toussaint, Aurélie Untas, Piotr Milkiewicz, Henriette Ytting, Laura Buck, David E. Jones, Gideon Morris Hirschfield, Angela Leburgue, Christoph Schramm et al. · 2025 · The Lancet. Gastroenterology & hepatology
  9. Quality of life in Dutch patients with primary biliary cholangitis: Discrepancies between patients’ perspectives and objective disease parameters
    Rozanne C. de Veer, Maria C. van Hooff, Geraldine da Silva, Maren H. Harms, Herold Johnny Metselaar, José Willemse, Elaine Utomo, Adriaan J. van der Meer · 2023 · Hepatology Research
  10. Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluations Following Single Oral Doses of GSK2330672 in Healthy Japanese Volunteers
    Hiroko Ino, Akira Endo, Akira Wakamatsu, Hirofumi Ogura, Yotaro Numachi, Stuart F. W. Kendrick · 2018 · Clinical Pharmacology in Drug Development
  11. Primary biliary cholangitis patients exhibit MRI changes in structure and function of interoceptive brain regions
    Victoria Mosher, Mark G. Swain, Jack X. Q. Pang, Gilaad G. Kaplan, Keith A. Sharkey, GLENDA M. MacQUEEN, Bradley Gordon Goodyear · 2019 · PLoS ONE
  12. ADAM Metalloproteinase Domain 17 Regulates Cholestasis-Associated Liver Injury and Sickness Behavior Development in Mice
    Wagdi Almishri, Liam A. Swain, Charlotte D’Mello, Tyson S. Le, Stefan J. Urbanski, Henry H. Nguyen · 2022 · Frontiers in Immunology
  13. Serum bile acid change correlates with improvement in pruritus in patients with primary biliary cholangitis receiving linerixibat
    Eleni Karatza, Brandon Swift, Fernando Carreño, Sumanta Mukherjee, Linda Casillas, Janelle L. Lennie, James Fettiplace, Megan McLaughlin, Andreas Emanuel Kremer · 2024 · Liver International
  14. A home-based exercise programme attenuates fatigue in primary biliary cholangitis: Results from the EXCITED clinical trial
    Alice Freer, Felicity Rhian Williams, Simon Durman, Jennifer K. Hayden, Matthew James Armstrong, Palak Jitendrakumar Trivedi · 2024 · JHEP Reports
  15. Symptoms Burden and Health-related Quality of Life in Chinese Patients with Primary Biliary Cholangitis
    Yansheng Liu, Siyuan Tian, Gui Jia, Zheyi Han, Changcun Guo, Yulong Shang, Ying Han · 2021 · Journal of Clinical and Translational Hepatology
  16. Rituximab for the treatment of fatigue in primary biliary cholangitis (formerly primary biliary cirrhosis): a randomised controlled trial
    Amardeep Khanna, Laura Jopson, Denise Howel, Andrew Bryant, Andrew Matthew Blamire, Julia L. Newton, Jennifer S. Wilkinson, Alison J. Steel, Jennifer Bainbridge, Renae J. Stefanetti et al. · 2018 · Efficacy and Mechanism Evaluation
  17. Management of Fatigue in Primary Biliary Cholangitis
    Amardeep Khanna, Vinod S. Hegade, David E. Jones · 2019 · Current Hepatology Reports
  18. Quality of Life in Patients with Primary Biliary Cholangitis: A Single-Center Experience in Serbia
    Tamara Milovanovic Alempijevic, Dusan Dj. Popovic, Milica Stojković Lalošević, Igor Dumic, Sanja Dragašević, Tomica Milosavljević · 2020 · Digestive Diseases
  19. Bezafibrate for the Treatment of Cholestatic Pruritus: Time for a Change in Management?
    Jessica Katharine Dyson, David E.J. Jones · 2020 · Gastroenterology
  20. The feasibility and acceptability of an online mind-body wellness program for patients with primary biliary cholangitis
    Makayla Watt, Ashley M. Hyde, John C. Spence, Gail M Wright, Shauna Vander Well, Emily Johnson, Andrew L. Mason, Magnus McLeod, Puneeta Tandon · 2023 · Canadian Liver Journal
  21. Risk Stratification in Primary Biliary Cholangitis
    Francesco Martini, Daniele Balducci, Martina Mancinelli, Valerio Buzzanca, Elena Fracchia, Giuseppe Tarantino, A. Benedetti, Marco Marzioni, Luca Maroni · 2023 · Journal of Clinical Medicine
  22. Quality of life among patients with autoimmune hepatitis in remission
    Atsushi Takahashi, Masanori Abe, Tetsuya Yasunaka, Teruko Arinaga‐Hino, Kazumichi Abe, Akinobu Takaki, Takuji Torimura, Mikio Zeniya, Kaname Yoshizawea, Jong‐Hon Kang et al. · 2020 · Medicine
  23. Joint Analysis of Genetic Correlation, Mendelian Randomization and Colocalization Highlights the Bi-Directional Causal Association Between Hypothyroidism and Primary Biliary Cirrhosis
    Yanjun Wang, Ping Guo, Yanan Zhang, Lu Liu, Ran Yan, Zhongshang Yuan, Yongfeng Song · 2021 · Frontiers in Genetics
  24. Translation and validation of the Serbian primary biliary cholangitis-40 questionnaire
    Simon Zec, Dusan Dj. Popovic, Vera Matovic, Vladimir Nikolić, Ksenija Bojović, Jasna Jović, Ljiljana Marković Denić, Tomica Milosavljević, Tamara Milovanovic Alempijevic · 2017 · PLoS ONE
  25. The Treatment of Primary Biliary Cholangitis: Time for Personalized Medicine
    Xinyi Men, Yansheng Liu, Han Zhao, Bingrui Xie, Changcun Guo, Patrick S.C. Leung, Suraj Timilsina, Merrill Eric Gershwin, Yulong Shang, Ying Han · 2025 · Clinical Reviews in Allergy & Immunology
  26. Pharmacologic management of primary sclerosing cholangitis: what’s in the pipeline?
    Jaspreet S. Suri, Vilas R. Patwardhan, Alan Bonder · 2019 · Expert Review of Gastroenterology & Hepatology
  27. Fatigue in chronic hepatitis B patients is significant and associates with autonomic dysfunction
    Hong Wang, Ying Zhou, Rong Yan, Guo Qing Ru, Lili Yu, Jiong Yao · 2019 · Health and Quality of Life Outcomes
  28. Primary Biliary Cholangitis: Promising Emerging Innovative Therapies and Their Impact on GLOBE Scores
    Aalam Sohal, K. Kowdley · 2023 · Hepatic Medicine : Evidence and Research
  29. Utility of ElastPQ point-shear wave elastography in the work-up of patients with primary sclerosing cholangitis
    Davide Roccarina, Francesca Saffioti, Matteo Rosselli, Aileen Marshall, Massimo Pinzani, Douglas Thorburn · 2023 · JHEP Reports
  30. The role of bile salts in itch receptor activation
    Frank Wolters, Dagmar Tolenaars, Michel van Weeghel, Dirk Rudi de Waart, Stan F.J. van de Graaf, Coen C. Paulusma, Arthur J. Verhoeven, Ulrich H. Beuers, Ronald P.J. Oude Elferink · 2025 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  31. Primary biliary cholangitis: current insights and novel therapies
    Alessandro Granito, Γεώργιος Παππάς, Lucia Napoli, Benedetta Stefanini, Daniela Tirotta, Paolo Muratori · 2026 · Expert Review of Clinical Immunology
  32. Depressive symptom as a risk factor for cirrhosis in patients with primary biliary cholangitis: Analysis based on Lasso‐logistic regression and decision tree models
    Simin Zhou, Jiwen Li, Jiangpeng Liu, Shijing Dong, Nian Chen, Ying Ran, Haifeng Liu, Xiaoyi Wang, Hui Yang, Man Liu et al. · 2024 · Brain and Behavior
  33. Symptom burden in chronic liver disease
    Ammar Hassan, I. Hurtado-Díaz de León, Elliot B. Tapper · 2023 · Gastroenterology report
  34. A Systems Model for Ursodeoxycholic Acid Metabolism in Healthy and Patients With Primary Biliary Cirrhosis
    Peiying Zuo, Robert L. Dobbins, R. O’Connor‐Semmes, MA Young · 2016 · CPT Pharmacometrics & Systems Pharmacology
  35. Serum Bile Acid Elevation is an Independently Associated With Pruritus in Patients With At-risk Metabolic Dysfunction-associated Steatotic Liver Disease
    Zobair M. Younossi, Michael J. Estep, Sean C. Felix, Brian P Lam, Sumanta Mukherjee, Brandon Swift, Linda Casillas, Andréa Ribeiro de Souza, Jake N. Hunnicutt, Megan McLaughlin et al. · 2025 · Journal of Clinical and Experimental Hepatology
  36. S3-Leitlinie „Seltene Lebererkrankungen (LeiSe LebEr) – Autoimmune Lebererkrankungen von der Pädiatrie bis zum Erwachsenenalter“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)
    Autorinnen/Autoren, Collaborators · 2025 · Zeitschrift für Gastroenterologie
  37. Primary biliary cholangitis. Treatment options in 2025. A narrative review
    Maria Angelara, K. Papachristou, M. Papatheodoridi, N. Nasiri-Ansari, Dimitrios S. Karagiannakis, T. Androutsakos · 2025 · Frontiers in Immunology
  38. Symptom Reporting in Patients with Primary Biliary Cholangitis: Higher Burden of Symptom Detection Using an Interactive App
    Jimmy Daza, Nathally Espinosa Montagut, Achim Kautz, Diane Langenbacher, Michael Hetjens, Fabian P. Siegel, Matthias P. Ebert, Andreas Teufel · 2025 · Digestive Diseases
  39. Health-related quality of life questionnaires used in primary biliary cholangitis: a systematic review
    Xin Ai, Xian Zi Yang, Haiyan Fu, Jiamin Xu, Yingmei Tang · 2022 · Scandinavian Journal of Gastroenterology
  40. High-dose oral thiamine versus placebo for chronic fatigue in patients with primary biliary cholangitis: A crossover randomized clinical trial
    Palle Bager, Lars Bossen, Rasmus Hvidbjerg Gantzel, Henning Grønbæk · 2024 · PLoS ONE
  41. Autoimmune liver diseases in the Asia Pacific region: proceedings of the autoimmune liver disease course at APASL 2025
    Atsushi Tanaka, Sombat Treeprasertsuk, Ming‐Ling Chang, Soek-Siam Tan, Cumali Efe, Sook‐Hyang Jeong, Xiong Ma, Martin Weltman, Hiroyuki Isayama, Jidong Jia · 2025 · Hepatology International
  42. Review Article: Targeting Peroxisome Proliferator‐Activated Receptors in Primary Biliary Cholangitis
    Jörn Markus Schattenberg, Jesús M. Bañales, Gideon Morris Hirschfield, Palak Trivedi, Edward E. Cable, Charles A. McWherter, Andrew N. Billin, Daria B. Crittenden, Grant R. Budas · 2026 · Alimentary Pharmacology & Therapeutics
  43. EASL-AASLD Delphi consensus statement on surrogate endpoints and real-world evidence in primary biliary cholangitis
    Cynthia Levy, Ana Lleo, Adrielly Martins, Miki Scaravaglio, Christopher L. Bowlus, Marco Carbone, Christophe Corpechot, Cláudia Alves Couto, Bettina E. Hansen, Gideon Morris Hirschfield et al. · 2026 · Journal of Hepatology
  44. EEG brain network variability is correlated with other pathophysiological indicators of critical patients in neurology intensive care unit
    Chunli Chen, Zhaojin Chen, Meiling Hu, Sha Zhou, Shiyun Xu, Guan Zhou, Jixuan Zhou, Yuqin Li, Baodan Chen, Dezhong Yao et al. · 2024 · Brain Research Bulletin
  45. Primary biliary cholangitis
    I. M. Iljinsky, O. M. Tsirulniкova · 2021 · Russian Journal of Transplantology and Artificial Organs
  46. The impact of undiagnosed primary biliary cholangitis
    Isabel Garrido, Rodrigo Liberal, Maria João Cardoso, Guilherme Macedo · 2021 · European Journal of Gastroenterology & Hepatology
  47. Development of a Question Prompt List for People Living With Primary Biliary Cholangitis: A Delphi Study
    Ellen Werner, Maria C. van Hooff, Gemma H.X. Weijsters, Nadir Abbas, Alessio Gerussi, José Willemse, Robert Mitchell-Thain, Angela Leburgue, Gideon Morris Hirschfield, Christophe Corpechot et al. · 2025 · Clinical Gastroenterology and Hepatology
  48. Pruritus and health-related quality of life in chronic liver disease: a longitudinal, survey-based cohort study
    Usha Gungabissoon, Jacob N. Hunnicutt, Eleanor McDermott, Andrew Lovley, Monica Frazer, Kaitlin LaGasse, Mark R. Kosinski, Kristen L. McCausland, Ashleigh A. McGirr, Helen T. Smith et al. · 2025 · BMJ Open Gastroenterology
  49. Association Between Quality of Life Defined by EuroQol Group 5 Dimension and Composite Inferior Outcome Among Inpatients with Cirrhosis
    Yangyang Hui, Han Wang, Gaoyue Guo, Wanting Yang, Xuqian Zhang, Jie Yang, Fang Yang, Xiaoyu Wang, Xiaofei Fan, Binxin Cui et al. · 2024 · Clinical Interventions in Aging
  50. Clinical characteristics of antimitochondrial antibody-positive patients at a safety net health care system in Arizona
    Susanna Yu Tan, Napatkamon Ayutyanont, Bikash Bhattarai, Zohreh Movahedi, Lakshmi Jayaram, Robert Gareth Gish, Abdul Nadir · 2017 · BMJ Open Gastroenterology
  51. Treatment response in primary biliary cholangitis: The role of autoimmune hepatitis features
    Fernando Mané, Hélder Cardoso, Rodrigo Liberal, Susana Lopes, Pedro Pereira, Regina Gonçalves, Guilherme Macedo · 2019 · Annals of Hepatology
  52. Development of a Theoretically Informed Web-Based Mind-Body Wellness Intervention for Patients With Primary Biliary Cholangitis: Formative Study
    Makayla Watt, John C. Spence, Puneeta Tandon · 2021 · JMIR Formative Research
  53. Chronic fatigue should not be overlooked in primary biliary cholangitis
    Endrit Shahini, Faiza Ahmed · 2021 · Journal of Hepatology
  54. Ileal Bile Acid Transport Inhibitors for Cholestatic Pruritus: A Primer
    Adrielly Martins, Cynthia Levy · 2025 · Current Hepatology Reports
  55. Primary Biliary Cholangitis Pathogenesis: A Pathophysiology-Based Narrative Review
    Klairi Papachristou, Maria Angelara, Konstantinos Manganas, Θεόδωρος Ανδρουτσάκος · 2026 · International Journal of Molecular Sciences
  56. Quality of Life in Patients With Variant Syndromes of Autoimmune Liver Diseases—A Cross‐Sectional Multicentre Study
    Natalie Uhlenbusch, Romée J.A.L.M. Snijders, Meike Mund, Maciej K. Janik, Piotr Milkiewicz, Bernd Löwe, Claudia Kroll, Joanna Raszeja‐Wyszomirska, Alessio Gerussi, Francesca Bolis et al. · 2026 · Liver International
  57. Exploring odevixibat’s efficacy in alagille syndrome: insights from recent clinical trials and IBAT inhibitor experiences
    Chaowapong Jarasvaraparn, Minna Rodrigo, Christopher Hartley, Wikrom W. Karnsakul · 2024 · Expert Opinion on Pharmacotherapy
  58. Associations between sleep disorders and clinical outcomes of patients with primary biliary cholangitis
    Shijing Dong, Simin Zhou, Jiangpeng Liu, Nian Chen, Jiwen Li, Zongze Han, Ruiyun Liu, Chenyang Xuan, Weirong Wang, Liping Guo et al. · 2024 · Advances in Medical Sciences
  59. Primary biliary cholangitis: assessment and management strategies
    S Nadir Abbas, David E. Jones, Yiannis N. Kallis, Laura Maher, Imran Patanwala · 2021 · Gastrointestinal Nursing
  60. Implementation of a care bundle improves PBC management
    Rachel Smith, Laura Burke, Nadir Abbas, Richard Aspinall, Douglas Thorburn, Michael A. Heneghan, Andrew D. Yeoman, Joanna Leithead, Conor Braniff, Robert Mitchell-Thain et al. · 2025 · JHEP Reports
  61. The role of HLA-G in primary biliary cholangitis and response to therapy
    Michela Miglianti, Stefano Mocci, Roberto Littera, Giancarlo Serra, Cinzia Balestieri, Maria Conti, Francesco Pes, Silvia Deidda, Michela Lorrai, Caterina Mereu et al. · 2025 · Frontiers in Immunology
  62. Fatigue and associated psychosocial factors in patients with liver cirrhosis: Prevalence, indicators and course. Results from the EnErGie study
    Fatuma Meyer, Karen Rischmüller, Mats Lukas Wiese, Lea Franziska Sautter, Susanne Esau, Josefine Müller, Luise Ehlers, Cornelia C. Metges, Peter A. Kropp, Leif‐Alexander Garbe et al. · 2025 · Clinical Nutrition ESPEN
  63. Update der S3-Leitlinie „Seltene Lebererkrankungen (LeiSe LebEr) – Autoimmune Lebererkrankungen von der Pädiatrie bis zum Erwachsenenalter“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Living guideline
    Marcial Sebode, Heike Bantel, Ulrich Baumann, Philip Bufler, Münevver Demir, Leona Dold, Verena Keitel, Reinhild Klein, Andreas Emanuel Kremer, Petra Lynen Jansen et al. · 2026 · Zeitschrift für Gastroenterologie
  64. Health-related quality of life and symptoms in autoimmune liver diseases
    Maciej K. Janik, Ewa Wunsch, Piotr Milkiewicz · 2023 · Minerva Gastroenterology
  65. Validation of PBC‐10 in Japanese patients with primary biliary cholangitis
    Akihito Takeuchi, Masanori Abe, Sachiko Furukawa, Tadashi Namisaki, Atsushi Takahashi, Kazumichi Abe, Kentaro Kikuchi, Ryo Miura, Naoko Tachizawa, Yoshinari Asaoka et al. · 2025 · Hepatology Research
  66. PBC-HOPE: A Randomized Controlled Trial of Hypnosis and Psychoeducation in Women With Primary Biliary Cholangitis and Fatigue
    Aurélie Untas, Cécile Goffette, Cécile Flahault, Christel Vioulac, Olivier Chazouillères, Pierre‐Antoine Soret, Karima Ben Belkacem, Farid Gaouar, Nathalie Bernard, Alexandra Rousseau et al. · 2025 · The American Journal of Gastroenterology
  67. A Case of Primary Biliary Cirrhosis Complicated with Inflammatory Bowel Disease Treated by Integrated Traditional Chinese and Western Medicine
    楠 沈 · 2021 · Traditional Chinese Medicine
  68. Primary Biliary Cholangitis
    Atsushi Tanaka, Patrick S.C. Leung, Christopher L. Bowlus, Merrill Eric Gershwin · 2020 · Springer eBooks
  69. Quality of Life and Physical Activity after Liver Transplantation. Literature Review.
    Marta Stępień–Słodkowska, Monika Niewiadomska, Katarzyna Kotarska · 2017 · Central European Journal of Sport Sciences and Medicine
  70. Moderne Therapie der primär biliären Cholangitis
    Christian P. Strassburg · 2017 · Der Internist
  71. Measurement properties of the PBC-40 and PBC-27: a Dutch validation study
    Rozanne C. de Veer, Geraldine da Silva, Maria C. van Hooff, Maren H. Harms, Herold Johnny Metselaar, José Willemse, Elaine Utomo, Adriaan J van der Meer · 2021 · BMJ Open Gastroenterology
  72. Cholestatic liver disease leads to significant adaptative changes in neural circuits regulating social behavior in mice to enhance sociability
    Wagdi Almishri, Mohammed O. Altonsy, Mark G. Swain · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  73. Anti‐Ro52/TRIM21 autoantibodies predict Sjögren's syndrome in patients with primary biliary cholangitis
    Marie Louise Næstholt Dahl, Trine‐Line Korsholm, Jakob Hauge Mikkelsen, Malene Hvid, Ayad Babaee, Matias Hauge Böttcher, Jesper Bach Hansen, Peter Holland‐Fischer, Christian Brix Folsted Andersen, Henning Grønbæk et al. · 2025 · Hepatology Research
  74. Ileal Bile Acid Transporter Inhibitors for Adult Patients with Autoimmune Cholestatic Liver Diseases: A Systematic Review and Meta-Analysis
    Igor Boechat Silveira, Rodolfo Augusto Assis Rezende, Carlos Alberto Monteiro Leitão Neto, Yohanna Idsabella Rossi, Marina de Assis Bezerra Cavalcanti Leite, Guilherme Grossi Lopes Cançado · 2025 · Gastroenterology Insights
  75. EASL position paper on palliative care in advanced chronic liver disease
    Sumita Verma, Matthias Pinter, Lucia Macken, Patrizia Künzler‐Heule, Lise Lotte Gluud, Robert Bart Takkenberg, Rui Nunes, Liana Gheorghe, Wendy M. Prentice, Ben Hudson · 2026 · JHEP Reports
  76. From unmet needs to new possibilities: PPAR-targeted therapies in the journey of people living with Primary Biliary Cholangitis
    Antonella Ruiu, Maria Pia Calabrese, Pietro Meschisi, Riccardo Plebani, Buzias Maria, Ana Lleò, Vincenzo Ronca · 2026 · European Journal of Internal Medicine
  77. Primär biliäre Cholangitis – etablierte und neue Therapien
    Marcel Vetter, Andreas Emanuel Kremer · 2018 · Der Internist
  78. Self-reported experiences of patients living with primary biliary cholangitis (PBC): Are we treating the liver but not the patient?
    Kathleen P. Ismond, Bishoi Aziz, Gail M Wright, Andrew L. Mason · 2019 · Canadian Liver Journal
  79. [Apolipoprotein B and small, dense LDL-C].
    Yasuki Ito · 2012 · PubMed
  80. Assessing and managing symptom burden and quality of life in primary sclerosing cholangitis patients
    Josiah D. McCain, David M. H. Chascsa, Keith D. Lindor · 2021 · Expert Opinion on Orphan Drugs
  81. Annual Meeting of the Canadian Association for the Study of the Liver (CASL), the Canadian Network on Hepatitis C (CanHepC), the Canadian Association of Hepatology Nurses (CAHN), and the Canadian NASH Network 2022 Abstracts
    2022 · Canadian Liver Journal
  82. Ditch the Itch: Propofol in the Management of Cholestatic Pruritus
    Sowmya Kruttiventi, Jessica Olcott, Brock J. Doubledee · 2023 · Clinical Pediatrics
  83. Primary Biliary Cholangitis
    Atsushi Tanaka, Merrill Eric Gershwin · 2019 · Elsevier eBooks
  84. Autoimmune Lebererkrankungen – ein Update (Teil 2)
    Ida Schregel, Silja Steinmann, Christoph Schramm · 2022 · Gastroenterologie up2date
  85. Primary Biliary Cholangitis in Motion Meeting
    Lois Skellon · 2018 · EMJ Hepatology
  86. Holistic Patient Care in Primary Biliary Cholangitis: Managing Both the Disease and the Symptoms
    Eleanor Roberts · 2022 · EMJ Hepatology
  87. Editorial: rapid assessment of health‐related quality of life in primary biliary cholangitis—no excuse not to ask
    Aliya F. Gulamhusein, Nathan D. Jackson · 2019 · Alimentary Pharmacology & Therapeutics
  88. Hepatobiliary Diseases
    Wiebke Pirschel, Andreas Emanuel Kremer · 2016 · Springer eBooks
  89. Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acid
    Dunn, Sarah, Evans, Lysbeth, Kennedy, Ciara, Wafer, Rebecca, Moody, Sam, Wolstenhulme, Faye, Burton, Emma, Konkoth, Ann Breeze, Fisher, Holly, Chadwick, Thomas et al. · 2026 · BMJ Open
  90. Molecular mechanisms of pruritus in cholestasis
    Andreas Emanuel Kremer · 2015 · UvA-DARE (University of Amsterdam)
  91. Challenges and opportunities in the management of portal hypertension
    Imran Patanwala · 2015
  92. Primary Biliary Cholangitis
    David E. Jones · 2018 · Wiley eBooks
  93. Symptoms, Chronic Disease, and Patient Management
    David E. Jones · 2020
  94. Психологічні особливості пацієнтів з хронічною неінфекційною гепатологічною патологією
    Kateryna Skurat · 2019 · DOAJ (DOAJ: Directory of Open Access Journals)
  95. Transplant and Autoimmune Diseases
    Martina Gambato, Francesco Paolo Russo · 2021 · Springer eBooks
  96. Defining and Characterising a Toolkit for the Development of a Successful European Registry for Rare Liver Diseases.
    Marinos Pericleous, Mary Bythel, Michael L. Schilsky, Anil Kumar Dhawan, Claire Kelly, Aftab Ala · 2021 · Research Square
  97. Primary Biliary Cholangitis
    Andrew R. Scheinberg, Cynthia Levy · 2022 · Current treatment options in gastroenterology
  98. Hardiness and quality of life in NAFLD patients: pilot study
    Kateryna Skurat · 2021 · Psychosomatic Medicine and General Practice
  99. Challenges for diagnosis and treatment of primary biliary cholangitis
    Atsushi Tanaka · 2023 · Elsevier eBooks
  100. Answering Pivotal Questions in the Diagnosis and Treatment of Primary Biliary Cirrhosis and Non-Alcoholic Steatohepatitis
    Ewen Legg · 2015 · EMJ Hepatology